Abstract
This chapter covers the gamut of intracranial venous issues, ranging from the most common entity—developmental venous anomalies—to the nonexistent: “chronic cerebrospinal venous insufficiency.”
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lasjaunias P, Burrows P, Planet C. Developmental venous anomalies (DVA): the so-called venous angioma. Neurosurg Rev. 1986;9(3):233–42. (Review) (In eng). http://www.ncbi.nlm.nih.gov/pubmed/3550523.
Rigamonti D, Spetzler RF, Medina M, Rigamonti K, Geckle DS, Pappas C. Cerebral venous malformations. J Neurosurg. 1990;73(4):560–4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2398388.
Sarwar M, McCormick WF. Intracerebral venous angioma. Case report and review. Arch Neurol. 1978;35(5):323–5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=646686.
Iizuka Y, Kakihara T, Suzuki M, Komura S, Azusawa H. Endovascular remodeling technique for vein of Galen aneurysmal malformations—angiographic confirmation of a connection between the median prosencephalic vein and the deep venous system. Journal of neurosurgery. Pediatrics. 2008;1(1):75–8. (Case Reports) (In eng). https://doi.org/10.3171/PED-08/01/075.
Topper R, Jurgens E, Reul J, Thron A. Clinical significance of intracranial developmental venous anomalies. J Neurol Neurosurg Psychiatry. 1999;67(2):234–8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10407000.
Okudera T, Huang YP, Fukusumi A, Nakamura Y, Hatazawa J, Uemura K. Micro-angiographical studies of the medullary venous system of the cerebral hemisphere. Neuropathology. 1999;19(1):93–111. https://doi.org/10.1046/j.1440-1789.1999.00215.x.
Rigamonti D, Spetzler RF, Drayer BP, et al. Appearance of venous malformations on magnetic resonance imaging. J Neurosurg. 1988;69(4):535–9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2843614.
Dammann P, Wrede KH, Maderwald S, et al. The venous angioarchitecture of sporadic cerebral cavernous malformations: a susceptibility weighted imaging study at 7 T MRI. J Neurol Neurosurg Psychiatry. 2013;84(2):194–200. https://doi.org/10.1136/jnnp-2012-302599.
Aoki R, Srivatanakul K. Developmental venous anomaly: benign or not benign. Neurol Med Chir (Tokyo). 2016;56(9):534–43. https://doi.org/10.2176/nmc.ra.2016-0030.
Iv M, Fischbein NJ, Zaharchuk G. Association of developmental venous anomalies with perfusion abnormalities on arterial spin labeling and bolus perfusion-weighted imaging. J Neuroimaging. 2015;25(2):243–50. https://doi.org/10.1111/jon.12119.
San Millan Ruiz D, Delavelle J, Yilmaz H, et al. Parenchymal abnormalities associated with developmental venous anomalies. Neuroradiology. 2007;49(12):987–95. https://doi.org/10.1007/s00234-007-0279-0.
McLaughlin MR, Kondziolka D, Flickinger JC, Lunsford S, Lunsford LD. The prospective natural history of cerebral venous malformations. Neurosurgery. 1998;43(2):195–200. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9696070.
Pereira VM, Geibprasert S, Krings T, et al. Pathomechanisms of symptomatic developmental venous anomalies. Stroke. 2008;39(12):3201–15. (In eng). https://doi.org/10.1161/STROKEAHA.108.521799.
Im SH, Han MH, Kwon BJ, et al. Venous-predominant parenchymal arteriovenous malformation: a rare subtype with a venous drainage pattern mimicking developmental venous anomaly. J Neurosurg. 2008;108(6):1142–7. (In eng). https://doi.org/10.3171/JNS/2008/108/6/1142.
Sundaram SK, Michelhaugh SK, Klinger NV, et al. GNAQ mutation in the venous vascular malformation and underlying brain tissue in Sturge-Weber syndrome. Neuropediatrics. 2017;48(5):385–9. https://doi.org/10.1055/s-0037-1603515.
Yallapragada AV, Cure JK, Holden KR. Sturge-Weber syndrome variant with atypical intracranial findings: case report. J Child Neurol. 2006;21(2):155–7. https://doi.org/10.1177/08830738060210020801.
Kasasbeh AS, Kalaria A, Comi AM, Lo W, Lin DDM. Atypical intracerebral developmental venous anomalies in Sturge-Weber syndrome: a case series and review of literature. Pediatr Neurol. 2020;104:54–61. https://doi.org/10.1016/j.pediatrneurol.2019.08.002.
Voronovich ZA, Wolfe K, Foster K, Sorte D, Carlson AP. Restrictive cerebral cortical venopathy: a new clinicopathological entity. Interv Neuroradiol. 2019;25(3):322–9. https://doi.org/10.1177/1591019918821861.
Jenny B, Zerah M, Swift D, et al. Giant dural venous sinus ectasia in neonates. J Neurosurg Pediatr. 2010;5(5):523–8. https://doi.org/10.3171/2009.12.PEDS0862.
Akers A, Al-Shahi Salman R, Awad IA, et al. Synopsis of guidelines for the clinical management of cerebral cavernous malformations: consensus recommendations based on systematic literature review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel. Neurosurgery. 2017;80(5):665–80. https://doi.org/10.1093/neuros/nyx091.
Otten P, Pizzolato GP, Rilliet B, Berney J. [131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies]. Neurochirurgie 1989;35(2):82–3, 128–31. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2674753.
Del Curling O, Jr., Kelly DL, Jr., Elster AD, Craven TE. An analysis of the natural history of cavernous angiomas. J Neurosurg. 1991;75(5):702–8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1919691.
Robinson JR, Awad IA, Little JR. Natural history of the cavernous angioma. J Neurosurg. 1991;75(5):709–14. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1919692.
Rigamonti D, Drayer BP, Johnson PC, Hadley MN, Zabramski J, Spetzler RF. The MRI appearance of cavernous malformations (angiomas). J Neurosurg. 1987;67(4):518–24. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3655889.
Nimjee SM, Powers CJ, Bulsara KR. Review of the literature on de novo formation of cavernous malformations of the central nervous system after radiation therapy. Neurosurg Focus. 2006;21(1):e4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16859257.
Cutsforth-Gregory JK, Lanzino G, Link MJ, Brown RD Jr, Flemming KD. Characterization of radiation-induced cavernous malformations and comparison with a nonradiation cavernous malformation cohort. J Neurosurg. 2015;122(5):1214–22. https://doi.org/10.3171/2015.1.JNS141452.
Maraire JN, Awad IA. Intracranial cavernous malformations: lesion behavior and management strategies. Neurosurgery. 1995;37(4):591–605. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8559286.
Simard JM, Garcia-Bengochea F, Ballinger WE Jr, Mickle JP, Quisling RG. Cavernous angioma: a review of 126 collected and 12 new clinical cases. Neurosurgery. 1986;18(2):162–72. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3960293.
Wong JH, Awad IA, Kim JH. Ultrastructural pathological features of cerebrovascular malformations: a preliminary report. Neurosurgery. 2000;46(6):1454–9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10834648.
Clatterbuck RE, Eberhart CG, Crain BJ, Rigamonti D. Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations. J Neurol Neurosurg Psychiatry. 2001;71(2):188–92. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11459890.
Gault J, Sarin H, Awadallah NA, Shenkar R, Awad IA. Pathobiology of human cerebrovascular malformations: basic mechanisms and clinical relevance. Neurosurgery. 2004;55(1):1–16; discussion 16–7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15214969.
Wurm G, Schnizer M, Fellner FA. Cerebral cavernous malformations associated with venous anomalies: surgical considerations. Neurosurgery. 2005;57(1 Suppl):42–58; discussion 42–58. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15987569.
Porter RW, Detwiler PW, Spetzler RF, et al. Cavernous malformations of the brainstem: experience with 100 patients. J Neurosurg. 1999;90(1):50–8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10413155.
Porter RW, Detwiler PW, Spetzler RF. Infratentorial cavernous malformations. In: Winn HR, editor. Youmans neurological surgery. Philadelphia: Saunders; 2004. p. 2321–39.
Little JR, Awad IA, Jones SC, Ebrahim ZY. Vascular pressures and cortical blood flow in cavernous angioma of the brain. J Neurosurg. 1990;73(4):555–9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2398387.
Sasaki O, Tanaka R, Koike T, Koide A, Koizumi T, Ogawa H. Excision of cavernous angioma with preservation of coexisting venous angioma. Case report. J Neurosurg. 1991;75(3):461–4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1869949.
Perrini P, Lanzino G. The association of venous developmental anomalies and cavernous malformations: pathophysiological, diagnostic, and surgical considerations. Neurosurg Focus. 2006;21(1):e5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16859258.
Awad IA, Robinson JR Jr, Mohanty S, Estes ML. Mixed vascular malformations of the brain: clinical and pathogenetic considerations. Neurosurgery. 1993;33(2):179–88; discussion 188. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8367039.
Zabramski JM, Wascher TM, Spetzler RF, et al. The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg. 1994;80(3):422–32. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8113854.
Brunereau L, Labauge P, Tournier-Lasserve E, Laberge S, Levy C, Houtteville J-P. Familial form of intracranial cavernous angioma: MR imaging Findings in 51 Families 1. Radiology. 2000;214(1):209–16. http://radiology.rsnajnls.org/cgi/content/abstract/214/1/209.
Johnson EW, Marchuk DA, Zabramski JM. The genetics of cerebral cavernous malformations. In: Winn HR, editor. Youmans neurological surgery. Philadelphia: Saunders; 2004. p. 2299–304.
Moriarity JL, Wetzel M, Clatterbuck RE, et al. The natural history of cavernous malformations: a prospective study of 68 patients. Neurosurgery. 1999;44(6):1166–71; discussion 1172–3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10371615.
Marchuk DA, Gallione CJ, Morrison LA, et al. A locus for cerebral cavernous malformations maps to chromosome 7q in two families. Genomics. 1995;28(2):311–4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8530042.
Plummer NW, Zawistowski JS, Marchuk DA. Genetics of cerebral cavernous malformations. Curr Neurol Neurosci Rep. 2005;5(5):391–6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16131422.
Gunel M, Awad IA, Finberg K, et al. A founder mutation as a cause of cerebral cavernous malformation in Hispanic Americans. N Engl J Med. 1996;334(15):946–51. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8596595.
Craig HD, Gunel M, Cepeda O, et al. Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27. Hum Mol Genet. 1998;7(12):1851–8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9811928.
Brunereau L, Leveque C, Bertrand P, et al. Familial form of cerebral cavernous malformations: evaluation of gradient-spin-echo (GRASE) imaging in lesion detection and characterization at 1.5 T. Neuroradiology. 2001;43(11):973–9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11760804.
Lehnhardt F-G, von Smekal U, Ruckriem B, et al. Value of gradient-echo magnetic resonance imaging in the diagnosis of familial cerebral cavernous malformation. Arch Neurol. 2005;62(4):653–8. https://doi.org/10.1001/archneur.62.4.653.
Yun TJ, Na DG, Kwon BJ, et al. A T1 hyperintense perilesional signal aids in the differentiation of a cavernous angioma from other hemorrhagic masses. AJNR Am J Neuroradiol. 2008;29(3):494–500. (In eng). https://doi.org/10.3174/ajnr.A0847.
Houtteville JP. Brain cavernoma: a dynamic lesion. Surg Neurol. 1997;48(6):610–4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9400644.
Rigamonti D, Hadley MN, Drayer BP, et al. Cerebral cavernous malformations. Incidence and familial occurrence. N Engl J Med. 1988;319(6):343–7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3393196.
Gross BA, Du R. Hemorrhage from cerebral cavernous malformations: a systematic pooled analysis. J Neurosurg. 2017;126(4):1079–87. https://doi.org/10.3171/2016.3.JNS152419.
Giombini S, Morello G. Cavernous angiomas of the brain. Account of fourteen personal cases and review of the literature. Acta Neurochir. 1978;40(1–2):61–82. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=654971.
Katayama Y, Tsubokawa T, Maeda T, Yamamoto T. Surgical management of cavernous malformations of the third ventricle. J Neurosurg. 1994;80(1):64–72. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8271024.
Pozzati E, Acciarri N, Tognetti F, Marliani F, Giangaspero F. Growth, subsequent bleeding, and de novo appearance of cerebral cavernous angiomas. Neurosurgery. 1996;38(4):662–9; discussion 669–70. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8692382.
Flemming KD, Goodman BP, Meyer FB. Successful brainstem cavernous malformation resection after repeated hemorrhages during pregnancy. Surg Neurol. 2003;60(6):545–7; discussion 547–8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14670675.
Porter PJ, Willinsky RA, Harper W, Wallace MC. Cerebral cavernous malformations: natural history and prognosis after clinical deterioration with or without hemorrhage. J Neurosurg. 1997;87(2):190–7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9254081.
Kalani MY, Zabramski JM. Risk for symptomatic hemorrhage of cerebral cavernous malformations during pregnancy. J Neurosurg. 2013;118(1):50–5. https://doi.org/10.3171/2012.8.JNS12241.
Clatterbuck RE, Moriarity JL, Elmaci I, Lee RR, Breiter SN, Rigamonti D. Dynamic nature of cavernous malformations: a prospective magnetic resonance imaging study with volumetric analysis. J Neurosurg. 2000;93(6):981–6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11117871.
Kim D-S, Park Y-G, Choi J-U, Chung S-S, Lee K-C. An analysis of the natural history of cavernous malformations. Surg Neurol. 1997;48(1):9–17. http://www.sciencedirect.com/science/article/B6TCB-3RHD40Y-4/2/37b152081c0c5c4291e76b1b6aa5353d.
Al-Holou WN, O’Lynnger TM, Pandey AS, et al. Natural history and imaging prevalence of cavernous malformations in children and young adults. J Neurosurg Pediatr. 2012;9(2):198–205. https://doi.org/10.3171/2011.11.PEDS11390.
Moore SA, Brown RD Jr, Christianson TJ, Flemming KD. Long-term natural history of incidentally discovered cavernous malformations in a single-center cohort. J Neurosurg. 2014;120(5):1188–92. https://doi.org/10.3171/2014.1.JNS131619.
Kondziolka D, Lunsford LD, Kestle JR. The natural history of cerebral cavernous malformations. J Neurosurg. 1995;83(5):820–4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7472549.
Raychaudhuri R, Batjer HH, Awad IA. Intracranial cavernous angioma: a practical review of clinical and biological aspects. Surg Neurol. 2005;63(4):319–28; discussion 328. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15808709.
Vives KP, Gunel M, Awad IA. Surgical management of supratentorial cavernous malformations. In: Winn HR, editor. Youmans neurological surgery. Philadelphia: Saunders; 2004. p. 2305–19.
Awad I, Jabbour P. Cerebral cavernous malformations and epilepsy. Neurosurg Focus. 2006;21(1):e7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16859260.
Aiba T, Tanaka R, Koike T, Kameyama S, Takeda N, Komata T. Natural history of intracranial cavernous malformations. J Neurosurg. 1995;83(1):56–9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7782850.
Requena I, Arias M, Lopez-Ibor L, et al. Cavernomas of the central nervous system: clinical and neuroimaging manifestations in 47 patients. J Neurol Neurosurg Psychiatry. 1991;54(7):590–4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1895122.
Baumann CR, Acciarri N, Bertalanffy H, et al. Seizure outcome after resection of supratentorial cavernous malformations: a study of 168 patients. Epilepsia. 2007;48(3):559–63. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17346251.
Dammann P, Wrede K, Jabbarli R, et al. Outcome after conservative management or surgical treatment for new-onset epilepsy in cerebral cavernous malformation. J Neurosurg. 2017;126(4):1303–11. https://doi.org/10.3171/2016.4.JNS1661.
Baumann CR, Schuknecht B, Lo Russo G, et al. Seizure outcome after resection of cavernous malformations is better when surrounding hemosiderin-stained brain also is removed. Epilepsia. 2006;47(3):563–6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16529622.
Weber JP, Silbergeld DL, Winn HR. Surgical resection of epileptogenic cortex associated with structural lesions. Neurosurg Clin N Am. 1993;4(2):327–36. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8467218.
Bruneau M, Bijlenga P, Reverdin A, et al. Early surgery for brainstem cavernomas. Acta Neurochir. 2006;148(4):405–14. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16311840.
Zausinger S, Yousry I, Brueckmann H, Schmid-Elsaesser R, Tonn JC. Cavernous malformations of the brainstem: three-dimensional-constructive interference in steady-state magnetic resonance imaging for improvement of surgical approach and clinical results. Neurosurgery. 2006;58(2):322–30; discussion 322–30. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16462486.
Mathiesen T, Edner G, Kihlstrom L. Deep and brainstem cavernomas: a consecutive 8-year series. J Neurosurg. 2003;99(1):31–7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12854740.
Samii M, Eghbal R, Carvalho GA, Matthies C. Surgical management of brainstem cavernomas. J Neurosurg. 2001;95(5):825–32. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11702873.
Brown AP, Thompson BG, Spetzler RF. The two-point method: evaluating brain stem lesions. BNI Q. 1996;12:20–4.
Kikuta K, Nozaki K, Takahashi JA, Miyamoto S, Kikuchi H, Hashimoto N. Postoperative evaluation of microsurgical resection for cavernous malformations of the brainstem. J Neurosurg. 2004;101(4):607–12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15481714.
Pozzati E, Zucchelli M, Marliani AF, Riccioli LA. Bleeding of a familial cerebral cavernous malformation after prophylactic anticoagulation therapy. Case report. Neurosurg Focus. 2006;21(1):e15. http://www.ncbi.nlm.nih.gov/pubmed/16859253.
Labauge P, Denier C, Bergametti F, Tournier-Lasserve E. Genetics of cavernous angiomas. Lancet Neurol. 2007;6(3):237–44. https://doi.org/10.1016/S1474-4422(07)70053-4.
Flemming KD, Link MJ, Christianson TJ, Brown RD Jr. Use of antithrombotic agents in patients with intracerebral cavernous malformations. J Neurosurg. 2013;118(1):43–6. https://doi.org/10.3171/2012.8.JNS112050.
Schneble HM, Soumare A, Herve D, et al. Antithrombotic therapy and bleeding risk in a prospective cohort study of patients with cerebral cavernous malformations. Stroke. 2012;43(12):3196–9. https://doi.org/10.1161/STROKEAHA.112.668533.
Samaraskera N, Poorthuis M, Kontoh K, et al. Guidelines for the management of cerebral cavernous malformations in adults. Cavernoma Alliance UK. https://www.cavernoma.org.uk/wp-content/uploads/2015/03/final-CCM-guidelines.pdf.
Shih YH, Pan DH. Management of supratentorial cavernous malformations: craniotomy versus gammaknife radiosurgery. Clin Neurol Neurosurg. 2005;107(2):108–12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15708224.
Huang Y-C, Tseng C-K, Chang C-N, Wei K-C, Liao C-C, Hsu P-W. LINAC radiosurgery for intracranial cavernous malformation: 10-year experience. Clin Neurol Neurosurg. 2006;108(8):750–6. http://www.sciencedirect.com/science/article/B6T5F-4JYKMTK-1/2/440af801a6a1f8e71d5d7a1b300a6f33.
Liscak R, Vladyka V, Simonova G, Vymazal J, Novotny J Jr. Gamma knife surgery of brain cavernous hemangiomas. J Neurosurg. 2005;102(Suppl):207–13. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15662812.
Kim MS, Pyo SY, Jeong YG, Lee SI, Jung YT, Sim JH. Gamma knife surgery for intracranial cavernous hemangioma. J Neurosurg. 2005;102(Suppl):102–6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15662789.
Liu KD, Chung WY, Wu HM, et al. Gamma knife surgery for cavernous hemangiomas: an analysis of 125 patients. J Neurosurg. 2005;102(Suppl):81–6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15662786.
Hasegawa T, McInerney J, Kondziolka D, Lee JY, Flickinger JC, Lunsford LD. Long-term results after stereotactic radiosurgery for patients with cavernous malformations. Neurosurgery. 2002;50(6):1190–7; discussion 1197–8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12015835.
Zhang N, Pan L, Wang BJ, Wang EM, Dai JZ, Cai PW. Gamma knife radiosurgery for cavernous hemangiomas. J Neurosurg. 2000;93(Suppl 3):74–7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11143267.
Pollock BE, Garces YI, Stafford SL, Foote RL, Schomberg PJ, Link MJ. Stereotactic radiosurgery for cavernous malformations. J Neurosurg. 2000;93(6):987–91. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11117872.
Regis J, Bartolomei F, Kida Y, et al. Radiosurgery for epilepsy associated with cavernous malformation: retrospective study in 49 patients. Neurosurgery. 2000;47(5):1091–7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11063101.
Mitchell P, Hodgson TJ, Seaman S, Kemeny AA, Forster DM. Stereotactic radiosurgery and the risk of haemorrhage from cavernous malformations. Br J Neurosurg. 2000;14(2):96–100. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10889879.
Lu XY, Sun H, Xu JG, Li QY. Stereotactic radiosurgery of brainstem cavernous malformations: a systematic review and meta-analysis. J Neurosurg. 2014;120(4):982–7. https://doi.org/10.3171/2013.12.JNS13990.
Coffey RJ. Brainstem cavernomas. J Neurosurg. 2003;99(6):1116–7; author reply 1117. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14705749.
Gewirtz RJ, Steinberg GK, Crowley R, Levy RP. Pathological changes in surgically resected angiographically occult vascular malformations after radiation. Neurosurgery. 1998;42(4):738–42; discussion 742–3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9574637.
McDonald DA, Shi C, Shenkar R, et al. Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease. Stroke. 2012;43(2):571–4. https://doi.org/10.1161/STROKEAHA.111.625467.
Shenkar R, Shi C, Austin C, et al. RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations. Stroke. 2017;48(1):187–94. https://doi.org/10.1161/STROKEAHA.116.015013.
Yamashita S, Okita K, Harada K, et al. Giant cavernous hepatic hemangioma shrunk by use of sorafenib. Clin J Gastroenterol. 2013;6(1):55–62. https://doi.org/10.1007/s12328-012-0343-0.
Herter T, Brandt M, Szuwart U. Cavernous hemangiomas in children. Childs Nerv Syst. 1988;4(3):123–7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3396017.
Scott RM, Barnes P, Kupsky W, Adelman LS. Cavernous angiomas of the central nervous system in children. J Neurosurg. 1992;76(1):38–46. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1727167.
Edwards M, Baumgartner J, Wilson C. Cavernous and other cryptic vascular malformations in the pediatric age group. In: Awad IA, Barrow DL, editors. Cavernous malformations. Park Ridge, IL: AANS; 1993. p. 163–83.
Gross BA, Du R, Orbach DB, Scott RM, Smith ER. The natural history of cerebral cavernous malformations in children. J Neurosurg Pediatr. 2015:1–6. https://doi.org/10.3171/2015.2.PEDS14541.
Amato MC, Madureira JF, Oliveira RS. Intracranial cavernous malformation in children: a single-centered experience with 30 consecutive cases. Arq Neuropsiquiatr. 2013;71(4):220–8. https://www.ncbi.nlm.nih.gov/pubmed/23588283.
Raybaud CA, Strother CM, Hald JK. Aneurysms of the vein of Galen: embryonic considerations and anatomical features relating to the pathogenesis of the malformation. Neuroradiology. 1989;31(2):109–28. (Review) (In eng) http://www.ncbi.nlm.nih.gov/pubmed/2664553.
Gailloud P, O’Riordan DP, Burger I, Lehmann CU. Confirmation of communication between deep venous drainage and the vein of Galen after treatment of a vein of Galen aneurysmal malformation in an infant presenting with severe pulmonary hypertension. AJNR Am J Neuroradiol. 2006;27(2):317–20. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16484400.
Lasjaunias P. Vascular diseases in neonates, infants, and children: interventional neuroradiology management. Berlin: Springer Verlag; 1997.
Gandolfo C, Krings T, Alvarez H, et al. Sinus pericranii: diagnostic and therapeutic considerations in 15 patients. Neuroradiology. 2007;49(6):505–14. (In eng). https://doi.org/10.1007/s00234-007-0211-7.
Sadler LR, Tarr RW, Jungreis CA, Sekhar L. Sinus pericranii: CT and MR findings. J Comput Assist Tomogr. 1990;14(1):124–7. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2298976.
Stromeyer L. Ueber sinus pericranii. Dtsch Klin 1850;2(160–161). (In German).
Mastin W. Venous blood tumors of the cranium in communication with the intracranial venous circulation, especially the sinuses of the dura mater. JAMA. 1886;7:309–30.
Vinas FC, Valenzuela S, Zuleta A. Literature review: sinus pericranii. Neurol Res. 1994;16(6):471–4. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7708140.
Rangel-Castilla L, Krishna C, Klucznik R, Diaz O. Endovascular embolization with Onyx in the management of sinus pericranii: a case report. Neurosurg Focus. 2009;27(5):E13. (In eng). https://doi.org/10.3171/2009.8.FOCUS09170.
Bonioli E, Bellini C, Palmieri A, Fondelli MP, Tortori DP. Radiological case of the month. Sinus pericranii. Arch Pediatr Adolesc Med. 1994;148(6):607–8. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8193685.
Buxton N, Vloeberghs M, Sinus pericranii. Report of a case and review of the literature. Pediatr Neurosurg. 1999;30(2):96–9. (In eng).
Ernemann U, Lowenheim H, Freudenstein D, Koerbel A, Heininger A, Tatagiba M. Hemodynamic evaluation during balloon test occlusion of the sigmoid sinus: clinical and technical considerations. AJNR Am J Neuroradiol. 2005;26(1):179–82. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15661723.
Cerqueira L, Reis FC. [Sinus pericranii and developmental venous anomalies: a frequent association]. Acta Med Port. 1995;8(4):239–42. (In por). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7625219.
Gabikian P, Clatterbuck RE, Gailloud P, Rigamonti D. Developmental venous anomalies and sinus pericranii in the blue rubber-bleb nevus syndrome. Case report. J Neurosurg. 2003;99(2):409–11. (In eng). https://doi.org/10.3171/jns.2003.99.2.0409.
Bollar A, Allut AG, Prieto A, Gelabert M, Becerra E. Sinus pericranii: radiological and etiopathological considerations. Case report. J Neurosurg. 1992;77(3):469–72. (In eng). https://doi.org/10.3171/jns.1992.77.3.0469.
Courville CB, Rocovich PM. A contribution to the study of sinus pericranii (Stromeyer); report of case with some comments on pathology of the lesion. Bull Los Angel Neurol Soc. 1946;11(3–4):145–58. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20285700.
Kihara S, Koga H, Tabuchi K. [Traumatic sinus pericranii. Case report]. Neurol Med Chir (Tokyo). 1991;31(13):982–5. (In jpn).
Sawamura Y, Abe H, Sugimoto S, et al. [Histological classification and therapeutic problems of sinus pericranii]. Neurol Med Chir (Tokyo). 1987;27(8):762–8. (In jpn). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2451161.
Kurosu A, Wachi A, Bando K, Kumami K, Naito S, Sato K. Craniosynostosis in the presence of a sinus pericranii: case report. Neurosurgery. 1994;34(6):1090–2; discussion 1092–3. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8084399.
Park SC, Kim SK, Cho BK, et al. Sinus pericranii in children: report of 16 patients and preoperative evaluation of surgical risk. J Neurosurg Pediatr. 2009;4(6):536–42. (In eng). https://doi.org/10.3171/2009.7.PEDS0994.
Anegawa S, Hayashi T, Torigoe R, Nakagawa S, Ogasawara T. Sinus pericranii with severe symptom due to transient disorder of venous return—case report. Neurol Med Chir. 1991;31(5):287–9. (Case Reports) (In eng). http://www.ncbi.nlm.nih.gov/pubmed/1717865.
Inci S, Turgut M, Saygi S, Ozdemir G. Sinus pericranii associated with epilepsy. Turk Neurosurg. 1996;6:21–4.
Carpenter JS, Rosen CL, Bailes JE, Gailloud P. Sinus pericranii: clinical and imaging findings in two cases of spontaneous partial thrombosis. AJNR Am J Neuroradiol. 2004;25(1):121–5. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14729540.
Rozen WM, Joseph S, Lo PA. Spontaneous involution of two sinus pericranii—a unique case and review of the literature. J Clin Neurosci. 2008;15(7):833–5. (In eng). https://doi.org/10.1016/j.jocn.2006.10.025.
Bigot JL, Iacona C, Lepreux A, Dhellemmes P, Motte J, Gomes H. Sinus pericranii: advantages of MR imaging. Pediatr Radiol. 2000;30(10):710–2. (Case Reports) (In eng). http://www.ncbi.nlm.nih.gov/pubmed/11075608.
Sheu M, Fauteux G, Chang H, Taylor W, Stopa E, Robinson-Bostom L. Sinus pericranii: dermatologic considerations and literature review. J Am Acad Dermatol. 2002;46(6):934–41. (In eng).
Brook AL, Gold MM, Farinhas JM, Goodrich JT, Bello JA. Endovascular transvenous embolization of sinus pericranii. Case report. J Neurosurg Pediatr. 2009;3(3):220–4. (Case Reports Review) (In eng). https://doi.org/10.3171/2008.10.PEDS08267.
Shaw WC. Folklore surrounding facial deformity and the origins of facial prejudice. Br J Plast Surg. 1981;34(3):237–46. (In eng). http://www.ncbi.nlm.nih.gov/pubmed/7272557.
Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg. 1982;69(3):412–22. (Research Support, Non-U.S. Gov’t) (In eng). http://www.ncbi.nlm.nih.gov/pubmed/7063565.
Donnelly LF, Adams DM, Bisset GS 3rd. Vascular malformations and hemangiomas: a practical approach in a multidisciplinary clinic. AJR Am J Roentgenol. 2000;174(3):597–608. (Review) (In eng). http://www.ncbi.nlm.nih.gov/pubmed/10701595.
Chung EM, Smirniotopoulos JG, Specht CS, Schroeder JW, Cube R. From the archives of the AFIP: pediatric orbit tumors and tumorlike lesions: nonosseous lesions of the extraocular orbit. Radiographics. 2007;27(6):1777–99. (Review) (In eng). https://doi.org/10.1148/rg.276075138.
Eifert S, Villavicencio JL, Kao TC, Taute BM, Rich NM. Prevalence of deep venous anomalies in congenital vascular malformations of venous predominance. J Vasc Surg. 2000;31(3):462–71. (In eng). http://www.ncbi.nlm.nih.gov/pubmed/10709058.
Podda S. Venous malformations. http://emedicine.medscape.com/article/1296303-overview.
Puig S, Aref H, Chigot V, Bonin B, Brunelle F. Classification of venous malformations in children and implications for sclerotherapy. Pediatr Radiol. 2003;33(2):99–103. (In eng). https://doi.org/10.1007/s00247-002-0838-9.
Bisdorff A, Mulliken JB, Carrico J, Robertson RL, Burrows PE. Intracranial vascular anomalies in patients with periorbital lymphatic and lymphaticovenous malformations. AJNR Am J Neuroradiol. 2007;28(2):335–41. (In eng). http://www.ncbi.nlm.nih.gov/pubmed/17297008.
Boon LM, Mulliken JB, Vikkula M, et al. Assignment of a locus for dominantly inherited venous malformations to chromosome 9p. Hum Mol Genet. 1994;3(9):1583–7. (Case Reports Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.) (In eng). http://www.ncbi.nlm.nih.gov/pubmed/7833915.
Klippel M, Trenaunay P. Du naevus variqueux osteohypertophique. Arch Gen Med. 1900;85:641–72.
Servelle M. Klippel and Trenaunay’s syndrome. 768 operated cases. Ann Surg. 1985;201(3):365–73. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2983626.
Alomari AI, Orbach DB, Mulliken JB, et al. Klippel-Trenaunay syndrome and spinal arteriovenous malformations: an erroneous association. AJNR Am J Neuroradiol. 2010;31(9):1608–12. (In eng). https://doi.org/10.3174/ajnr.A2167.
Chhajed M, Pandit S, Dhawan N, Jain A. Klippel-Trenaunay and Sturge-Weber overlap syndrome with phakomatosis pigmentovascularis. J Pediatr Neurosci. 2010;5(2):138–40. (In eng). https://doi.org/10.4103/1817-1745.76113.
Gallione CJ, Pasyk KA, Boon LM, et al. A gene for familial venous malformations maps to chromosome 9p in a second large kindred. J Med Genet. 1995;32(3):197–9. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7783168.
Bilaniuk LT. Vascular lesions of the orbit in children. Neuroimaging Clin N Am. 2005;15(1):107–20. (In eng). https://doi.org/10.1016/j.nic.2005.03.001.
Deveikis JP. Percutaneous ethanol sclerotherapy for vascular malformations in the head and neck. Arch Facial Plast Surg. 2005;7(5):322–5. (Comparative Study Review) (In eng). https://doi.org/10.1001/archfaci.7.5.322.
Wright JE, Sullivan TJ, Garner A, Wulc AE, Moseley IF. Orbital venous anomalies. Ophthalmology. 1997;104(6):905–13. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9186428.
Greene AK, Burrows PE, Smith L, Mulliken JB. Periorbital lymphatic malformation: clinical course and management in 42 patients. Plast Reconstr Surg. 2005;115(1):22–30. (In eng).
Baker LL, Dillon WP, Hieshima GB, Dowd CF, Frieden IJ. Hemangiomas and vascular malformations of the head and neck: MR characterization. AJNR Am J Neuroradiol. 1993;14(2):307–14. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8456703.
Barnes PD, Burrows PE, Hoffer FA, Mulliken JB. Hemangiomas and vascular malformations of the head and neck: MR characterization. AJNR Am J Neuroradiol. 1994;15(1):193–5. (Comment Letter) (In eng). http://www.ncbi.nlm.nih.gov/pubmed/8141056.
Fordham LA, Chung CJ, Donnelly LF. Imaging of congenital vascular and lymphatic anomalies of the head and neck. Neuroimaging Clin N Am. 2000;10(1):117–36, viii. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10658158.
Marler JJ, Mulliken JB. Current management of hemangiomas and vascular malformations. Clin Plast Surg. 2005;32(1):99–116, ix. (In eng). https://doi.org/10.1016/j.cps.2004.10.001.
Hill RA, Pho RW, Kumar VP. Resection of vascular malformations. J Hand Surg Br. 1993;18(1):17–21. (In eng). http://www.ncbi.nlm.nih.gov/pubmed/8436852.
Legiehn GM, Heran MK. Venous malformations: classification, development, diagnosis, and interventional radiologic management. Radiol Clin N Am. 2008;46(3):545–97, vi. (In eng). https://doi.org/10.1016/j.rcl.2008.02.008.
Berenguer B, Burrows PE, Zurakowski D, Mulliken JB. Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg. 1999;104(1):1–11; discussion 12-5. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10597669.
Puig S, Aref H, Brunelle F. Double-needle sclerotherapy of lymphangiomas and venous angiomas in children: a simple technique to prevent complications. AJR Am J Roentgenol. 2003;180(5):1399–401. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12704058.
Mason KP, Michna E, Zurakowski D, Koka BV, Burrows PE. Serum ethanol levels in children and adults after ethanol embolization or sclerotherapy for vascular anomalies. Radiology. 2000;217(1):127–32. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11012433.
Spence J, Krings T, TerBrugge KG, Agid R. Percutaneous treatment of facial venous malformations: a matched comparison of alcohol and bleomycin sclerotherapy. Head Neck. 2011;33(1):125–30. (In eng). https://doi.org/10.1002/hed.21410.
Werner JA, Lippert BM, Hoffmann P, Rudert H. Nd: YAG laser therapy of voluminous hemangiomas and vascular malformations. Adv Otorhinolaryngol. 1995;49:75–80. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7653391.
Apfelberg DB. Intralesional laser photocoagulation-steroids as an adjunct to surgery for massive hemangiomas and vascular malformations. Ann Plast Surg. 1995;35(2):144–8; discussion 149. (In eng) http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7486735.
Dandy WE. Intracranial pressure without brain tumor: diagnosis and treatment. Ann Surg. 1937;106(4):492–513. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17857053.
Smith JL. Whence pseudotumor cerebri? J Clin Neuroophthalmol. 1985;5(1):55–6. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3156890.
Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 2002;59(10):1492–5. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12455560.
Karahalios DG, Rekate HL, Khayata MH, Apostolides PJ. Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies. Neurology. 1996;46(1):198–202. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8559374.
Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol. 1988;45(8):875–7. (In eng) http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3395261.
Radhakrishnan K, Thacker AK, Bohlaga NH, Maloo JC, Gerryo SE. Epidemiology of idiopathic intracranial hypertension: a prospective and case-control study. J Neurol Sci. 1993;116(1):18–28. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8509801.
Radhakrishnan K, Ahlskog JE, Cross SA, Kurland LT, O’Fallon WM. Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976 to 1990. Arch Neurol. 1993;50(1):78–80. (In eng) http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8418804.
Bruce BB, Kedar S, Van Stavern GP, et al. Idiopathic intracranial hypertension in men. Neurology. 2009;72(4):304–9. (In eng). https://doi.org/10.1212/01.wnl.0000333254.84120.f5.
Kesler A, Fattal-Valevski A. Idiopathic intracranial hypertension in the pediatric population. J Child Neurol. 2002;17(10):745–8. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12546428.
Johnston I. The historical development of the pseudotumor concept. Neurosurg Focus. 2001;11(2):E2. (In eng).
Najjar MW, Azzam NI, Khalifa MA. Pseudotumor cerebri: disordered cerebrospinal fluid hydrodynamics with extra-axial CSF collections. Pediatr Neurosurg. 2005;41(4):212–5. (In eng). https://doi.org/10.1159/000086564.
Levine DN. Ventricular size in pseudotumor cerebri and the theory of impaired CSF absorption. J Neurol Sci. 2000;177(2):85–94. (In eng).
Bateman GA. Vascular hydraulics associated with idiopathic and secondary intracranial hypertension. AJNR Am J Neuroradiol. 2002;23(7):1180–6. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12169478.
Bloomfield GL, Ridings PC, Blocher CR, Marmarou A, Sugerman HJ. A proposed relationship between increased intra-abdominal, intrathoracic, and intracranial pressure. Crit Care Med. 1997;25(3):496–503. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9118668.
Sugerman HJ, Felton IW 3rd, Sismanis A, et al. Continuous negative abdominal pressure device to treat pseudotumor cerebri. Int J Obes Relat Metab Disord. 2001;25(4):486–90. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11319651.
Kesler A, Kliper E, Shenkerman G, Stern N. Idiopathic intracranial hypertension is associated with lower body adiposity. Ophthalmology. 2010;117(1):169–74. (In eng). https://doi.org/10.1016/j.ophtha.2009.06.030.
Farb RI, Vanek I, Scott JN, et al. Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology. 2003;60(9):1418–24. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12743224.
Brazis PW. Pseudotumor cerebri. Curr Neurol Neurosci Rep. 2004;4(2):111–6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14984682.
Stienen A, Weinzierl M, Ludolph A, Tibussek D, Hausler M. Obstruction of cerebral venous sinus secondary to idiopathic intracranial hypertension. Eur J Neurol. 2008;15(12):1416–8. (In eng). https://doi.org/10.1111/j.1468-1331.2008.02340.x.
De Simone R, Marano E, Fiorillo C, et al. Sudden re-opening of collapsed transverse sinuses and longstanding clinical remission after a single lumbar puncture in a case of idiopathic intracranial hypertension. Pathogenetic implications. Neurol Sci. 2005;25(6):342–4. (In eng). https://doi.org/10.1007/s10072-004-0368-3.
Pickard JD, Czosnyka Z, Czosnyka M, Owler B, Higgins JN. Coupling of sagittal sinus pressure and cerebrospinal fluid pressure in idiopathic intracranial hypertension—a preliminary report. Acta Neurochir Suppl. 2008;102:283–5. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19388330.
Bono F, Giliberto C, Mastrandrea C, et al. Transverse sinus stenoses persist after normalization of the CSF pressure in IIH. Neurology. 2005;65(7):1090–3. (In eng). https://doi.org/10.1212/01.wnl.0000178889.63571.e5.
Rohr A, Dorner L, Stingele R, Buhl R, Alfke K, Jansen O. Reversibility of venous sinus obstruction in idiopathic intracranial hypertension. AJNR Am J Neuroradiol. 2007;28(4):656–9. https://www.ncbi.nlm.nih.gov/pubmed/17416816.
Wall M. Idiopathic intracranial hypertension. Neurol Clin. 2010;28(3):593–617. (In eng). https://doi.org/10.1016/j.ncl.2010.03.003.
Sorensen PS, Krogsaa B, Gjerris F. Clinical course and prognosis of pseudotumor cerebri. A prospective study of 24 patients. Acta Neurol Scand. 1988;77(2):164–72. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3364156.
Radhakrishnan K, Ahlskog JE, Garrity JA, Kurland LT. Idiopathic intracranial hypertension. Mayo Clin Proc. 1994;69(2):169–80. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8309269.
Degnan AJ, Levy LM. Narrowing of Meckel’s cave and cavernous sinus and enlargement of the optic nerve sheath in Pseudotumor Cerebri. J Comput Assist Tomogr. 2011;35(2):308–12. (In eng). https://doi.org/10.1097/RCT.0b013e31820d7a70.
Skau M, Brennum J, Gjerris F, Jensen R. What is new about idiopathic intracranial hypertension? An updated review of mechanism and treatment. Cephalalgia. 2006;26(4):384–99. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16556239.
Sugerman HJ, Felton WL 3rd, Sismanis A, Kellum JM, DeMaria EJ, Sugerman EL. Gastric surgery for pseudotumor cerebri associated with severe obesity. Ann Surg. 1999;229(5):634–40; discussion 640–2. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10235521.
Higgins JN, Owler BK, Cousins C, Pickard JD. Venous sinus stenting for refractory benign intracranial hypertension. Lancet. 2002;359(9302):228–30. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11812561.
Owler BK, Allan R, Parker G, Besser M. Pseudotumour cerebri, CSF rhinorrhoea and the role of venous sinus stenting in treatment. Br J Neurosurg. 2003;17(1):79–83. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12779209.
Ogungbo B, Roy D, Gholkar A, Mendelow AD. Endovascular stenting of the transverse sinus in a patient presenting with benign intracranial hypertension. Br J Neurosurg. 2003;17(6):565–8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14756490.
Metellus P, Levrier O, Fuentes S, et al. [Endovascular treatment of benign intracranial hypertension by stent placement in the transverse sinus. Therapeutic and pathophysiological considerations illustrated by a case report]. Neurochirurgie. 2005;51(2):113–20. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16107086.
Bussiere M, Falero R, Nicolle D, Proulx A, Patel V, Pelz D. Unilateral transverse sinus stenting of patients with idiopathic intracranial hypertension. AJNR Am J Neuroradiol. 2010;31(4):645–50. (In eng). https://doi.org/10.3174/ajnr.A1890.
Feldon SE. Visual outcomes comparing surgical techniques for management of severe idiopathic intracranial hypertension. Neurosurg Focus. 2007;23(5):E6. (In eng). https://doi.org/10.3171/FOC-07/11/E6.
Ahmed RM, Wilkinson M, Parker GD, et al. Transverse sinus stenting for idiopathic intracranial hypertension: a review of 52 patients and of model predictions. AJNR Am J Neuroradiol. 2011. (In Eng).; https://doi.org/10.3174/ajnr.A2575.
Nicholson P, Brinjikji W, Radovanovic I, et al. Venous sinus stenting for idiopathic intracranial hypertension: a systematic review and meta-analysis. J Neurointerv Surg. 2019;11(4):380–5. https://doi.org/10.1136/neurintsurg-2018-014172.
Garner RM, Aldridge JB, Wolfe SQ, Fargen KM. Quality of life, need for retreatment, and the re-equilibration phenomenon after venous sinus stenting for idiopathic intracranial hypertension. J Neurointerv Surg. 2021;13(1):79–85. https://doi.org/10.1136/neurintsurg-2020-016124.
Cutforth R, Wiseman J, Sutherland RD. The genesis of the cervical venous hum. Am Heart J. 1970;80(4):488–92. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=5471210
Cochran JH Jr, Kosmicki PW. Tinnitus as a presenting symptom in pernicious anemia. Ann Otol Rhinol Laryngol. 1979;88(2 Pt 1):297. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=443725.
Biousse V, Newman NJ, Lessell S. Audible pulsatile tinnitus in idiopathic intracranial hypertension. Neurology. 1998;50(4):1185–6. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9566427.
Saitoh Y, Takeda N, Yagi R, Oshima K, Kubo T, Yoshimine T. Pneumocephalus causing pulsatile tinnitus. Case illustration. J Neurosurg. 2000;92(3):505. (In eng). https://doi.org/10.3171/jns.2000.92.3.0505.
Adler JR, Ropper AH. Self-audible venous bruits and high jugular bulb. Arch Neurol. 1986;43(3):257–9. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3947273.
Dietz RR, Davis WL, Harnsberger HR, Jacobs JM, Blatter DD. MR imaging and MR angiography in the evaluation of pulsatile tinnitus. AJNR Am J Neuroradiol. 1994;15(5):879–89. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8059655.
Ward PH, Babin R, Calcaterra TC, Konrad HR. Operative treatment of surgical lesions with objective tinnitus. Ann Otol Rhinol Laryngol. 1975;84(4 Pt 1):473–82. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1155883.
Buckwalter JA, Sasaki CT, Virapongse C, Kier EL, Bauman N. Pulsatile tinnitus arising from jugular megabulb deformity: a treatment rationale. Laryngoscope. 1983;93(12):1534–9. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=6645753.
Lam BL, Schatz NJ, Glaser JS, Bowen BC. Pseudotumor cerebri from cranial venous obstruction. Ophthalmology. 1992;99(5):706–12. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1594215.
Marks MP, Dake MD, Steinberg GK, Norbash AM, Lane B. Stent placement for arterial and venous cerebrovascular disease: preliminary experience. Radiology. 1994;191(2):441–6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8153318.
Zenteno M, Murillo-Bonilla L, Martinez S, et al. Endovascular treatment of a transverse-sigmoid sinus aneurysm presenting as pulsatile tinnitus. Case report. J Neurosurg. 2004;100(1):120–2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14743922.
Herman JM, Spetzler RF, Bederson JB, Kurbat JM, Zabramski JM. Genesis of a dural arteriovenous malformation in a rat model. J Neurosurg. 1995;83(3):539–45. (In eng). https://doi.org/10.3171/jns.1995.83.3.0539.
Lawton MT, Jacobowitz R, Spetzler RF. Redefined role of angiogenesis in the pathogenesis of dural arteriovenous malformations. J Neurosurg. 1997;87(2):267–74. (In eng). https://doi.org/10.3171/jns.1997.87.2.0267.
Gerlach R, Boehm-Weigert M, Berkefeld J, et al. Thrombophilic risk factors in patients with cranial and spinal dural arteriovenous fistulae. Neurosurgery. 2008;63(4):693–8; discussion 698–9. (In eng). https://doi.org/10.1227/01.NEU.0000325730.77263.7E.
Kraus JA, Stuper BK, Muller J, et al. Molecular analysis of thrombophilic risk factors in patients with dural arteriovenous fistulas. J Neurol. 2002;249(6):680–2. (In eng). https://doi.org/10.1007/s00415-002-0690-8.
Saito A, Takahashi N, Furuno Y, et al. Multiple isolated sinus dural arteriovenous fistulas associated with antithrombin III deficiency—case report. Neurol Med Chir (Tokyo). 2008;48(10):455–9. (In eng).
Ozawa T, Miyasaka Y, Tanaka R, Kurata A, Fujii K. Dural-pial arteriovenous malformation after sinus thrombosis. Stroke. 1998;29(8):1721–4. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9707217.
Lasjaunias P, Chiu M, ter Brugge K, Tolia A, Hurth M, Bernstein M. Neurological manifestations of intracranial dural arteriovenous malformations. J Neurosurg. 1986;64(5):724–30. (In eng). https://doi.org/10.3171/jns.1986.64.5.0724.
Hademenos GJ, Massoud TF. Risk of intracranial arteriovenous malformation rupture due to venous drainage impairment. A theoretical analysis. Stroke. 1996;27(6):1072–83. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8650717.
Troffkin NA, Graham CB 3rd, Berkmen T, Wakhloo AK. Combined transvenous and transarterial embolization of a tentorial-incisural dural arteriovenous malformation followed by primary stent placement in the associated stenotic straight sinus. Case report. J Neurosurg. 2003;99(3):579–83. (In eng). https://doi.org/10.3171/jns.2003.99.3.0579.
Liebig T, Henkes H, Brew S, Miloslavski E, Kirsch M, Kuhne D. Reconstructive treatment of dural arteriovenous fistulas of the transverse and sigmoid sinus: transvenous angioplasty and stent deployment. Neuroradiology. 2005;47(7):543–51. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15906020.
Challa VR, Moody DM, Brown WR. Vascular malformations of the central nervous system. J Neuropathol Exp Neurol. 1995;54(5):609–21. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7666048.
Song JK, Patel AB, Duckwiler GR, et al. Adult pial arteriovenous fistula and superior sagittal sinus stenosis: angiographic evidence for high-flow venopathy at an atypical location. Case report. J Neurosurg. 2002;96(4):792–5. (In eng). https://doi.org/10.3171/jns.2002.96.4.0792.
Dorne H, Zaidat OO, Fiorella D, et al. Chronic cerebrospinal venous insufficiency and the doubtful promise of an endovascular treatment for multiple sclerosis. J NeuroIntervent Surg. 2010;2:309–11.
Zamboni P, Galeotti R, Menegatti E, et al. Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2009;80(4):392–9. (In eng). https://doi.org/10.1136/jnnp.2008.157164.
Zivadinov R, Schirda C, Dwyer MG, et al. Chronic cerebrospinal venous insufficiency and iron deposition on susceptibility-weighted imaging in patients with multiple sclerosis: a pilot case-control study. Int Angiol. 2010;29(2):158–75. (In eng).
Zamboni P, Galeotti R, Menegatti E, et al. A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency. J Vasc Surg. 2009;50(6):–1348, 58. e1–3. (In eng). https://doi.org/10.1016/j.jvs.2009.07.096.
Moisse K. Multiple scerosis: studies probe role of clogged neck veins. http://abcnews.go.com/Health/MindMoodNews/multiple-sclerosis-studies-probe-role-clogged-neck-veins/story?id=13374572.
Sundstrom P, Wahlin A, Ambarki K, Birgander R, Eklund A, Malm J. Venous and cerebrospinal fluid flow in multiple sclerosis: a case-control study. Ann Neurol. 2010;68(2):255–9. (In eng). https://doi.org/10.1002/ana.22132.
Doepp F, Paul F, Valdueza JM, Schmierer K, Schreiber SJ. No cerebrocervical venous congestion in patients with multiple sclerosis. Ann Neurol. 2010;68(2):173–83. (In eng). https://doi.org/10.1002/ana.22085.
Yamout B, Herlopian A, Issa Z, et al. Extracranial venous stenosis is an unlikely cause of multiple sclerosis. Mult Scler. 2010;16(11):1341–8. (In eng). https://doi.org/10.1177/1352458510385268.
Baracchini C, Perini P, Calabrese M, Causin F, Rinaldi F, Gallo P. No evidence of chronic cerebrospinal venous insufficiency at multiple sclerosis onset. Ann Neurol. 2011;69(1):90–9. (In eng). https://doi.org/10.1002/ana.22228.
Costello F, Modi J, Lautner D, et al. Validity of the diagnostic criteria for chronic cerebrospinal venous insufficiency and association with multiple sclerosis. CMAJ. 2014;186(11):E418–26. https://doi.org/10.1503/cmaj.131431.
Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372(9648):1502–17. (In eng). https://doi.org/10.1016/S0140-6736(08)61620-7.
Thapar A, Lane TR, Pandey V, et al. Internal jugular thrombosis post venoplasty for chronic cerebrospinal venous insufficiency. Phlebology. 2011. (In Eng). https://doi.org/10.1258/phleb.2011.011052.
Khan O, Filippi M, Freedman MS, et al. Chronic cerebrospinal venous insufficiency and multiple sclerosis. Ann Neurol. 2010;67(3):286–90. (In eng). https://doi.org/10.1002/ana.22001.
Siddiqui AH, Zivadinov R, Benedict RH, et al. Prospective randomized trial of venous angioplasty in MS (PREMiSe). Neurology. 2014;83(5):441–9. https://doi.org/10.1212/WNL.0000000000000638.
Bourdette DN, Cohen JA. Venous angioplasty for “CCSVI” in multiple sclerosis: ending a therapeutic misadventure. Neurology. 2014;83(5):388–9. https://doi.org/10.1212/WNL.0000000000000651.
Silvis SM, de Sousa DA, Ferro JM, Coutinho JM. Cerebral venous thrombosis. Nat Rev Neurol. 2017;13(9):555–65. https://doi.org/10.1038/nrneurol.2017.104.
Otite FO, Patel S, Sharma R, et al. Trends in incidence and epidemiologic characteristics of cerebral venous thrombosis in the United States. Neurology. 2020;95(16):e2200–13. https://doi.org/10.1212/WNL.0000000000010598.
Coutinho JM, Zuurbier SM, Aramideh M, Stam J. The incidence of cerebral venous thrombosis: a cross-sectional study. Stroke. 2012;43(12):3375–7. https://doi.org/10.1161/STROKEAHA.112.671453.
Devasagayam S, Wyatt B, Leyden J, Kleinig T. Cerebral venous sinus thrombosis incidence is higher than previously thought: a retrospective population-based study. Stroke. 2016;47(9):2180–2. https://doi.org/10.1161/STROKEAHA.116.013617.
Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med. 2005;352(17):1791–8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15858188.
Bousser MG, Ferro JM. Cerebral venous thrombosis: an update. Lancet Neurol. 2007;6(2):162–70. https://doi.org/10.1016/S1474-4422(07)70029-7.
Maqueda VM, Thijs V. Risk of thromboembolism after cerebral venous thrombosis. Eur J Neurol. 2006;13(3):302–5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16618351.
Siudut J, Swiat M, Undas A. Altered fibrin clot properties in patients with cerebral venous sinus thrombosis: association with the risk of recurrence. Stroke. 2015;46(9):2665–8. https://doi.org/10.1161/STROKEAHA.115.009528.
Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med. 1998;338(25):1793–7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9632445.
de Bruijn SF, Stam J, Koopman MM, Vandenbroucke JP. Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users and in [correction of who are] carriers of hereditary prothrombotic conditions. The Cerebral Venous Sinus Thrombosis Study Group. BMJ. 1998;316(7131):589–92. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9518910.
Arxer A, Pardina B, Blas I, Ramio L, Villalonga A. Dural sinus thrombosis in a late preeclamptic woman. Can J Anaesth. 2004;51(10):1050–1. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15574564.
Wysokinska EM, Wysokinski WE, Brown RD, et al. Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis. Neurology. 2008;70(8):627–33. (In eng). https://doi.org/10.1212/01.wnl.0000297195.97325.a8.
Zapanta PE, Chi DH, Faust RA. A unique case of Bezold’s abscess associated with multiple dural sinus thromboses. Laryngoscope. 2001;111(11 Pt 1):1944–8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11801974.
Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35(3):664–70. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14976332.
Ciccone A, Canhao P, Falcao F, Ferro JM, Sterzi R. Thrombolysis for cerebral vein and dural sinus thrombosis. Cochrane Database Syst Rev. 2004;(1):CD003693. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14974030.
Ferro JM, Lopes MG, Rosas MJ, Fontes J. Delay in hospital admission of patients with cerebral vein and dural sinus thrombosis. Cerebrovasc Dis. 2005;19(3):152–6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15644627.
Lenz RA, Saver J. Venous sinus thrombosis in a patient taking thalidomide. Cerebrovasc Dis. 2004;18(2):175–7. (In eng). https://doi.org/10.1159/000079739.
Masjuan J, Pardo J, Callejo JM, Andres MT, Alvarez-Cermeno JC. Tamoxifen: a new risk factor for cerebral sinus thrombosis. Neurology. 2004;62(2):334–5. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14745086.
Finelli PF, Carley MD. Cerebral venous thrombosis associated with epoetin alfa therapy. Arch Neurol. 2000;57(2):260–2. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10681086.
Guimaraes J, Azevedo E. Phytoestrogens as a risk factor for cerebral sinus thrombosis. Cerebrovasc Dis. 2005;20(2):137–8. (In eng). https://doi.org/10.1159/000086805.
Nakase H, Shin Y, Nakagawa I, Kimura R, Sakaki T. Clinical features of postoperative cerebral venous infarction. Acta Neurochir. 2005;147(6):621–6; discussion 626. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15770350.
Emir M, Ozisik K, Cagli K, Bakuy V, Ozisik P, Sener E. Dural sinus thrombosis after cardiopulmonary bypass. Perfusion. 2004;19(2):133–5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15162929.
Berroir S, Grabli D, Heran F, Bakouche P, Bousser MG. Cerebral sinus venous thrombosis in two patients with spontaneous intracranial hypotension. Cerebrovasc Dis. 2004;17(1):9–12. (In eng). https://doi.org/10.1159/000073892.
Yoon KW, Cho MK, Kim YJ, Lee SK. Sinus thrombosis in a patient with intracranial hypotension: a suggested hypothesis of venous stasis. A case report. Interv Neuroradiol. 2011;17(2):248–51. (In eng).
Miglis MG, Levine DN. Intracranial venous thrombosis after placement of a lumbar drain. Neurocrit Care. 2010;12(1):83–7. (In eng). https://doi.org/10.1007/s12028-009-9278-9.
De Cruz P, Lust M, Trost N, Wall A, Gerraty R, Connell WR. Cerebral venous thrombosis associated with ulcerative colitis. Intern Med J. 2008;38(11):865–7. (In eng). https://doi.org/10.1111/j.1445-5994.2008.01749.x.
Skaiaa SC, Stave H. Recurrent sagittal sinus thrombosis occurring at high altitude during expeditions to Cho Oyu. Wilderness Environ Med. 2006;17(2):132–6. (In eng). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16805150.
Tan M, Deveber G, Shroff M, et al. Sagittal sinus compression is associated with neonatal cerebral sinovenous thrombosis. Pediatrics. 2011;128(2):e429–35. (In eng). https://doi.org/10.1542/peds.2010-3896.
Coutinho JM, Zuurbier SM, Gaartman AE, et al. Association between anemia and cerebral venous thrombosis: case-control study. Stroke. 2015;46(10):2735–40. https://doi.org/10.1161/STROKEAHA.115.009843.
Marjot T, Yadav S, Hasan N, Bentley P, Sharma P. Genes associated with adult cerebral venous thrombosis. Stroke. 2011;42(4):913–8. (In eng). https://doi.org/10.1161/STROKEAHA.110.602672.
Cotlarciuc I, Marjot T, Khan MS, et al. Towards the genetic basis of cerebral venous thrombosis-the BEAST Consortium: a study protocol. BMJ Open. 2016;6(11):e012351. https://doi.org/10.1136/bmjopen-2016-012351.
Oppenheim C, Domigo V, Gauvrit JY, et al. Subarachnoid hemorrhage as the initial presentation of dural sinus thrombosis. AJNR Am J Neuroradiol. 2005;26(3):614–7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15760875.
Spitzer C, Mull M, Rohde V, Kosinski CM. Non-traumatic cortical subarachnoid haemorrhage: diagnostic work-up and aetiological background. Neuroradiology. 2005;47(7):525–31. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15971064.
Chik Y, Gottesman RF, Zeiler SR, Rosenberg J, Llinas RH. Differentiation of transverse sinus thrombosis from congenitally atretic cerebral transverse sinus with CT. Stroke. 2012;43(7):1968–70. https://doi.org/10.1161/STROKEAHA.112.656124.
Singh R, Cope WP, Zhou Z, De Witt ME, Boockvar JA, Tsiouris AJ. Isolated cortical vein thrombosis: case series. J Neurosurg. 2015;123(2):427–33. https://doi.org/10.3171/2014.9.JNS141813.
Yang Q, Duan J, Fan Z, et al. Early detection and quantification of cerebral venous thrombosis by magnetic resonance black-blood thrombus imaging. Stroke. 2016;47(2):404–9. https://doi.org/10.1161/STROKEAHA.115.011369.
Lee DJ, Ahmadpour A, Binyamin T, Dahlin BC, Shahlaie K, Waldau B. Management and outcome of spontaneous cerebral venous sinus thrombosis in a 5-year consecutive single-institution cohort. J Neurointerv Surg. 2017;9(1):34–8. https://doi.org/10.1136/neurintsurg-2015-012237.
Ritchey Z, Hollatz AL, Weitzenkamp D, et al. Pediatric cortical vein thrombosis: frequency and association with venous infarction. Stroke. 2016;47(3):866–8. https://doi.org/10.1161/STROKEAHA.115.011291.
Coutinho JM, Gerritsma JJ, Zuurbier SM, Stam J. Isolated cortical vein thrombosis: systematic review of case reports and case series. Stroke. 2014;45(6):1836–8. https://doi.org/10.1161/STROKEAHA.113.004414.
Coutinho JM, Stam J, Canhao P, et al. Cerebral venous thrombosis in the absence of headache. Stroke. 2015;46(1):245–7. https://doi.org/10.1161/STROKEAHA.114.007584.
Afifi K, Bellanger G, Buyck PJ, et al. Features of intracranial hemorrhage in cerebral venous thrombosis. J Neurol. 2020;267(11):3292–8. https://doi.org/10.1007/s00415-020-10008-0.
Zuurbier SM, van den Berg R, Troost D, Majoie CB, Stam J, Coutinho JM. Hydrocephalus in cerebral venous thrombosis. J Neurol. 2015;262(4):931–7. https://doi.org/10.1007/s00415-015-7652-4.
Plewa MC, Tadi P, Gupta M. Cavernous sinus thrombosis. Treasure Island, FL: StatPearls; 2022.
Tanislav C, Siekmann R, Sieweke N, et al. Cerebral vein thrombosis: clinical manifestation and diagnosis. BMC Neurol. 2011;11:69. (In eng). https://doi.org/10.1186/1471-2377-11-69.
Liberman AL, Merkler AE, Gialdini G, et al. Risk of pulmonary embolism after cerebral venous thrombosis. Stroke. 2017;48(3):563–7. https://doi.org/10.1161/STROKEAHA.116.016316.
Coutinho JM, Zuurbier SM, Stam J. Declining mortality in cerebral venous thrombosis: a systematic review. Stroke. 2014;45(5):1338–41. https://doi.org/10.1161/STROKEAHA.113.004666.
Ferro JM, Canhao P, Bousser MG, Stam J, Barinagarrementeria F. Cerebral vein and dural sinus thrombosis in elderly patients. Stroke. 2005;36(9):1927–32. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16100024.
Canhao P, Ferro JM, Lindgren AG, Bousser MG, Stam J, Barinagarrementeria F. Causes and predictors of death in cerebral venous thrombosis. Stroke. 2005;36(8):1720–5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16002765.
Baldini T, Asioli GM, Romoli M, et al. Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus-2 infection: a systematic review and meta-analysis. Eur J Neurol. 2021;28(10):3478–90. https://doi.org/10.1111/ene.14727.
Taquet M, Husain M, Geddes JR, Luciano S, Harrison PJ. Cerebral venous thrombosis and portal vein thrombosis: a retrospective cohort study of 537,913 COVID-19 cases. EClinicalMedicine. 2021;39:101061. https://doi.org/10.1016/j.eclinm.2021.101061.
Abdalkader M, Shaikh SP, Siegler JE, et al. Cerebral venous sinus thrombosis in COVID-19 patients: a multicenter study and review of literature. J Stroke Cerebrovasc Dis. 2021;30(6):105733. https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105733.
Ghosh R, Roy D, Mandal A, et al. Cerebral venous thrombosis in COVID-19. Diabetes Metab Syndr. 2021;15(3):1039–45. https://doi.org/10.1016/j.dsx.2021.04.026.
Franchini M, Liumbruno GM, Pezzo M. COVID-19 vaccine-associated immune thrombosis and thrombocytopenia (VITT): diagnostic and therapeutic recommendations for a new syndrome. Eur J Haematol. 2021;107(2):173–80. https://doi.org/10.1111/ejh.13665.
Cleaver J, Ibitoye R, Morrison H, et al. Endovascular treatment for vaccine-induced cerebral venous sinus thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccination: a report of three cases. J Neurointerv Surg. 2022;14(9):853–7. https://doi.org/10.1136/neurintsurg-2021-018238.
Pavord S, Scully M, Hunt BJ, et al. Clinical features of vaccine-induced immune thrombocytopenia and thrombosis. N Engl J Med. 2021;385(18):1680–9. https://doi.org/10.1056/NEJMoa2109908.
Wong BY, Hickman S, Richards M, Jassar P, Wilson T. Management of paediatric otogenic cerebral venous sinus thrombosis: a systematic review. Clin Otolaryngol. 2015;40(6):704–14. https://doi.org/10.1111/coa.12504.
Cundiff DK. Anticoagulants for cerebral venous thrombosis: harmful to patients? Stroke. 2014;45(1):298–304. https://doi.org/10.1161/STROKEAHA.113.003519.
Einhaupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet. 1991;338(8767):597–600. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1679154.
Masuhr F, Mehraein S. Cerebral venous and sinus thrombosis: patients with a fatal outcome during intravenous dose-adjusted heparin treatment. Neurocrit Care. 2004;1(3):355–61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16174934.
Coutinho JMMD, Ferro JMMDP, Canhao PMDP, et al. Unfractionated or low-molecular weight heparin for the treatment of cerebral venous thrombosis. Stroke. 2010;41(11):2575–80. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=ovftl&AN=00007670-201011000-00023.
van Nuenen BF, Munneke M, Bloem BR. Cerebral venous sinus thrombosis: prevention of recurrent thromboembolism. Stroke. 2005;36(9):1822–3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16120838.
Einhaupl K, Stam J, Bousser MG, et al. EFNS guideline on the treatment of cerebral venous and sinus thrombosis in adult patients. Eur J Neurol. 2010;17(10):1229–35. (In eng). https://doi.org/10.1111/j.1468-1331.2010.03011.x.
Li G, Zeng X, Hussain M, et al. Safety and validity of mechanical thrombectomy and thrombolysis on severe cerebral venous sinus thrombosis. Neurosurgery. 2013;72(5):730–8.; discussion 730. https://doi.org/10.1227/NEU.0b013e318285c1d3.
Siddiqui FM, Dandapat S, Banerjee C, et al. Mechanical thrombectomy in cerebral venous thrombosis: systematic review of 185 cases. Stroke. 2015;46(5):1263–8. https://doi.org/10.1161/STROKEAHA.114.007465.
Chow K, Gobin YP, Saver J, Kidwell C, Dong P, Vinuela F. Endovascular treatment of dural sinus thrombosis with rheolytic thrombectomy and intra-arterial thrombolysis. Stroke. 2000;31(6):1420–5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10835466.
Liebetrau M, Mayer TE, Bruning R, Opherk C, Hamann GF. Intra-arterial thrombolysis of complete deep cerebral venous thrombosis. Neurology. 2004;63(12):2444–5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15623729.
Smith AG, Cornblath WT, Deveikis JP. Local thrombolytic therapy in deep cerebral venous thrombosis. Neurology. 1997;48(6):1613–9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9191776.
Wasay M, Bakshi R, Kojan S, Bobustuc G, Dubey N, Unwin DH. Nonrandomized comparison of local urokinase thrombolysis versus systemic heparin anticoagulation for superior sagittal sinus thrombosis. Stroke. 2001;32(10):2310–7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11588319.
Canhao P, Cortesao A, Cabral M, et al. Are steroids useful to treat cerebral venous thrombosis? Stroke. 2008;39(1):105–10. https://doi.org/10.1161/STROKEAHA.107.484089.
Aguiar de Sousa D, Canhao P, Ferro JM. Safety of pregnancy after cerebral venous thrombosis: a systematic review. Stroke. 2016;47(3):713–8. https://doi.org/10.1161/STROKEAHA.115.011955.
Rajan Vivakaran TT, Srinivas D, Kulkarni GB, Somanna S. The role of decompressive craniectomy in cerebral venous sinus thrombosis. J Neurosurg. 2012;117(4):738–44. https://doi.org/10.3171/2012.6.JNS11102.
Ferro JM, Crassard I, Coutinho JM, et al. Decompressive surgery in cerebrovenous thrombosis: a multicenter registry and a systematic review of individual patient data. Stroke. 2011(In Eng). https://doi.org/10.1161/STROKEAHA.111.615393.
Heller C, Heinecke A, Junker R, et al. Cerebral venous thrombosis in children: a multifactorial origin. Circulation. 2003;108(11):1362–7. https://doi.org/10.1161/01.CIR.0000087598.05977.45.
Sebire G, Tabarki B, Saunders DE, et al. Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome. Brain. 2005;128(Pt 3):477–89. https://doi.org/10.1093/brain/awh412.
Lazzareschi I, Curatola A, Gatto A, et al. Diagnosis and management of cerebral venous sinus thrombosis in children: a single-center retrospective analysis. Childs Nerv Syst. 2021;37(1):153–60. https://doi.org/10.1007/s00381-020-04958-z.
Bonduel M, Sciuccati G, Hepner M, et al. Arterial ischemic stroke and cerebral venous thrombosis in children: a 12-year Argentinean registry. Acta Haematol. 2006;115(3–4):180–5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16549893.
Moharir MD, Shroff M, Pontigon AM, et al. A prospective outcome study of neonatal cerebral sinovenous thrombosis. J Child Neurol. 2011. (In Eng). https://doi.org/10.1177/0883073811408094.
Kolar P. Risk factors for central and branch retinal vein occlusion: a meta-analysis of published clinical data. J Ophthalmol. 2014;2014:724780. https://doi.org/10.1155/2014/724780.
Soon AK, de Oliveira PR, Chow DR. Anti-VEGF in a marathon runner’s retinopathy case. Case Rep Ophthalmol Med. 2016;2016:5756970. https://doi.org/10.1155/2016/5756970.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Harrigan, M.R., Deveikis, J.P. (2023). Venous Disorders and Cavernous Malformations. In: Handbook of Cerebrovascular Disease and Neurointerventional Technique. Contemporary Medical Imaging. Humana, Cham. https://doi.org/10.1007/978-3-031-45598-8_15
Download citation
DOI: https://doi.org/10.1007/978-3-031-45598-8_15
Published:
Publisher Name: Humana, Cham
Print ISBN: 978-3-031-45597-1
Online ISBN: 978-3-031-45598-8
eBook Packages: MedicineMedicine (R0)